N atural killer cells can recognize and attack infected, transformed, and foreign cells. Target cell specificity is controlled by the balance of signals imparted by inhibitory and stimulatory receptors. The known inhibitory receptors are specific for MHC class I molecules, and function to prevent NK cells from attacking cells expressing high levels of MHC class I molecules (1) (2) (3) . The known stimulatory receptors are specific for ligands which are often up-regulated in transformed, infected, or stressed cells (4, 5) .
Murine NK cells use two families of receptors for MHC class I recognition, both of which are encoded in the NK gene complex on chromosome 6: the Ly49 family (6, 7) and the CD94/NKG2 family (8) . The Ly49 gene family is composed of 10 or more genes in a given strain (9 -11) , with the majority of the genes clustered in a region spanning ϳ600 kb. Ly49 receptors bind directly to class Ia D and K MHC molecules. However, different Ly49 receptors bind to distinct sets of class I MHC alleles (reviewed in Ref. 3) .
Ly49 receptors are expressed in a variegated pattern, such that each receptor is expressed by 10 -50% of NK cells (reviewed in Refs. 3 and 12) . Receptor expression is quite stable once initiated, as suggested by experiments in which purified NK subsets are expanded in vitro or transferred in vivo (6, 13, 14) . Importantly, Ly49 receptors are expressed in an overlapping fashion, such that the average NK cell expresses three to four different receptors (15) . The different receptors are expressed with a considerable degree of independence, as indicated by the finding that the frequency of NK cells coexpressing a given Ly49 receptor pair or trio can be estimated by multiplying the frequencies of cells that express each of the receptors individually (the product rule) (12) . This unique variegated expression pattern of the Ly49 receptors suggest that the initial choice of which receptors are to be expressed in a developing NK cell is governed by a stochastic mechanism. Combinatorial expression of receptor genes creates a large and useful NK cell receptor repertoire.
Ly49 genes exhibit allelic polymorphism, allowing one to separately monitor the expression of each allele of a given gene using RNA analysis or allele-specific mAbs. Examination of Ly49 heterozygous mice has led to the finding that Ly49 genes are expressed in a predominantly monoallelic fashion (13, 16 -18) . For example, mAbs specific for Ly49A B6 or Ly49A BALB were used to demonstrate that most Ly49A ϩ NK cells express only one or the other Ly49A allele, with approximately equal likelihood, whereas a small subpopulation of cells expresses both alleles (18) . Similar results were obtained in the case of Ly49G2. In both cases, the frequencies of biallelic cells were somewhat higher than predicted by the product rule, suggesting that some cells are intrinsically more likely than others to initiate expression of the corresponding gene. Interestingly, in NK cells that coexpress Ly49A and Ly49G2, the expressed alleles may be on the same or different chromosomes, with approximately equal likelihood (17, 18) . Sorted populations expressing a given allele maintain expression of that allele as the cells proliferate in culture for at least a week, suggesting that the chosen allele is activated in a stable fashion (16, 18) . Based on these findings, we proposed that the initial choice of NK receptor genes for expression is imposed by mechanisms that act locally to stably regulate cis-acting control sequences associated with each Ly49 allele, independent of neighboring Ly49 genes or of the Ly49 allele on the opposite chromosome (12, 13) .
Monoallelic and variegated expression has been reported for other genes, including those for certain cytokines, the Pax-5 transcription factor, and olfactory receptors (19) . Therefore, the mechanisms involved are of general interest. One category of models to account for the variegated expression pattern of Ly49 genes postulates an important role for interactions or competition in cis between the various neighboring Ly49 genes in a given gene cluster. For example, it might be proposed that one or a few Ly49 genes in a given chromosomal array stably associate with master regulatory elements in or near the cluster, allowing only the chosen genes to be expressed. Another category of models would propose that each Ly49 gene is independently regulated, with variegation arising as a consequence of limiting access of each gene to unidentified components necessary for stable activation of the gene. For example, the developmental time window allotted to assemble a complex of nuclear factors on a critical gene-activating regulatory element may be limiting, resulting in stable activation of a subset of the genes.
Because Ly49 gene expression is likely to involve chromatin level events such as chromatin remodeling, we began our investigations of Ly49 gene expression by examining the in vivo expression of ectopically integrated Ly49 transgenes. The approach was used to address whether variegated Ly49 gene expression involves interactions between different Ly49 genes in the normal multigene array, or occurs independently for each gene. Extending the approach allowed us to identify a novel element several kilobases upstream of the promoter that is required for Ly49A transgene expression.
Materials and Methods

Bacterial artificial chromosome (BAC) 4 library screening and plasmid construction
A C57BL/6J (B6) BAC library (Genome Systems, St. Louis, MO) was initially screened by hybridization with Ly49A B6 and Ly49C B6 cDNAs. BAC clones containing Ly49A, Ly49G2, or Ly49C were confirmed by hybridization with gene-specific oligonucleotide probes and ultimately by sequencing selected exons. Two BamH1-ClaI fragments containing Ly49A B6 genomic sequences were subcloned from BAC clone 101:A20 and rejoined to recreate the natural 30-kb BamHI fragment containing the complete Ly49A B6 gene. To construct the ⌬HS transgene, a 1.9-kb HindIIIXbaI fragment containing the hypersensitive site (HSS)-1 region was deleted from the upstream region of the 30-kb fragment. For sequencing upstream regions of Ly49G2 and Ly49C, we subcloned a 7-kb HindIII fragment from BAC clone 116:M19 and a 7-kb BamHI fragment from BAC clone 43:F9, respectively. The identities of the subclones were confirmed by partial exonic sequencing.
Mice
C57BL/6J (B6) and BALB.B (The Jackson Laboratory, Bar Harbor, ME) and transgenic mice were bred in the animal facility at the University of California, Berkeley. Transgenic founders were generated by injection of the purified genomic fragment into (CBA ϫ B6)F 2 fertilized oocytes. Transgenic founders were identified by PCR using a forward primer (5Ј-CGGTATATGGCTGTAGGGAGG-3Ј) homologous to sequences near the 3Ј end of the transgene, and a reverse primer (5Ј-GGCCGCTCTAGAAC TAGTGG-3Ј) homologous to the junction of the 3Ј end and a short polylinker sequence included in the transgene fragment. The transgene was backcrossed between two and five times to BALB.B mice. The backcrossed mice were selected based on typing for the NK complex (NKC) as previously described (18) To generate the mice examined in Fig. 3A , the backcrossed Ly49A transgenic (TG)2 line mice were crossed with BALB/c mice, and the previously described (20) Ly49G2 cDNA transgenic mice (on a C57BL/6 background) were crossed with BALB.B mice. Transgenic pups from each cross were intercrossed. Ly49A transgene ϩ NKC BALB/BALB pups were selected for analysis. Among these pups were H-2 b/b and H-2 b/d mice, as well as Ly49G2 transgene ϩ and Ly49G2 transgene Ϫ mice. Typing for the NKC and H-2 was as described (18) .
Quantitative PCR
Transgene copy number was determined by the kinetics of PCR amplification with a GeneAmp 5700 sequence detection using the SYBR Green reagent kit machine (PerkinElmer Applied Biosystems, Foster City, CA) according to manufacturer's instructions. Triplicate samples of tail DNA from transgenic mice of each line were analyzed concurrently against a standard curve of equivalent amounts of BALB.B tail DNA spiked with scaled concentrations of the transgene plasmid. Primers used were as follows: forward primer, 5Ј-ATCAGCACTCCTGAAAGACAAGCT-3Ј; reverse primer, 5Ј-TACACGCAAAACTGACCCTGTG-3Ј. Tail DNA was also amplified with ␥-actin primers (5Ј-GCACCTAGCACGATGAAGAT TAAG-3Ј and 5Ј-GCCACCGATCCAGACTGAGT-3Ј) as a control to normalize input DNA.
Antibodies
Anti-Ly49A B6 mAb A1 (21), anti-Ly49A BALB mAb TNTA (18) , and the anti-FcR mAb 2.4G2 (22) have been previously described. Abs were conjugated to FITC (Boehringer Mannheim, Mannheim, Germany) or biotin (Pierce, Rockland, IL). Anti-NK1.1-PE and DX5-PE conjugates were purchased from BD PharMingen (San Diego, CA). Anti-CD3-tricolor, anti-CD8-tricolor, streptavidin-tricolor, goat anti-mouse IgG, and mouse IgG were purchased from Caltag Laboratories (Burlingame, CA). Streptavidin-RED613 was purchased from Life Technologies (Rockville, MD).
Flow cytometry
Nylon wool nonadherent splenocytes were preincubated with 2.4G2 mAb to block FcRs. NK cell expression of the Ly49A transgene and endogenous Ly49A was determined by staining the cells with A1-FITC, TNTA-biotin, DX5-PE, anti-CD3-tricolor, and anti-CD8-tricolor followed by streptavidin-613. For comparable analysis of CD8 ϩ T cells, the cells were stained with anti-CD8-tricolor, anti-CD44-PE, A1-FITC, and TNTA-biotin, followed by streptavidin-613. To assess Ly49A
Tg expression on B cells, RBC-lysed splenocytes were preincubated with 2.4G2 mAb to block FcRs, and stained with anti-CD19-PE and A1-FITC. To assess Ly49A
Tg expression in peritoneal macrophages, cells were harvested by peritoneal lavage and stained with anti-MAC1-FITC and A1-biotin followed by streptavidin-PE. Flow-cytometric analysis was performed on Coulter XL-MCl flow cytometers at the University of California, Berkeley, Flow Cytometry facility. The FlowJo program (Tree Star, Ashland, OR) was used for further data analysis.
Northern blotting
Total RNA from various cells and organs was isolated with the Ultraspec RNA isolation solution (Biotecx Laboratories, Houston, TX) according to the manufacturer's instructions. A standard Northern blotting technique was used (23) with a full-length Ly49A cDNA probe. The hybridized blot was washed with 0.5ϫ SSC/1% SDS at 65°C for 1 h. After stripping, the blot was reprobed with an actin cDNA probe.
DNase I hypersensitivity assay
For analysis of NK cells, IL-2-activated A-LAK cells depleted of CD4 ϩ and CD8 ϩ T cells were prepared essentially as previously described (24) . After 7-9 days of culture, Ly49A
Ϫ and Ly49A ϩ cells were separated by staining with JR9-318-FITC and anti-FITC MACS beads and processing through an autoMACs machine (Miltenyi Biotec, Auburn, CA). The separated populations were Ͼ90% pure. Nuclei prepared as described (25) from ϳ5 ϫ 10 7 Ly49A Ϫ or Ly49A ϩ cells, were incubated with varying concentrations of DNase I (Sigma-Aldrich, St. Louis, MO) for 5 min at 37°C (25) . DNase I HSS in liver chromatin was assayed as described (26) . Following DNase I digestion, genomic DNA was purified, digested with a mixture of XbaI and BamHI enzymes, and analyzed by Southern blotting with the probes shown in Fig. 1A . After hybridization, the filters were washed with 0.5ϫ SSC/1% SDS at 65°C for 30 min.
DNA sequencing and alignments
Sequencing reactions were performed and resolved either with the Big Dye Terminator Ready Mix according to the manufacturer's instructions and an Applied Biosystems Prism 310 Sequencer (PerkinElmer Applied Biosystems), or by the Sequencing Facility at University of California, Berkeley. Sequences were aligned with CLUSTAL W (27) through VectorNTI (InforMax, Frederick, MD), and consensus binding sites were determined with the MacVector 7 program (Oxford Molecular, Oxford, U.K.).
Results
Mice harboring a genomic Ly49A
B6 transgene
We subcloned a 30-kb BamHI fragment containing the Ly49A gene from a B6-derived BAC (Fig. 1A) . The genomic fragment contains all seven exons of the Ly49A B6 gene, ϳ10 kb of upstream sequence and 3 kb of downstream sequence (28) . The purified 30-kb fragment was used to generate eight transgenic founders, each of which was backcrossed several times to BALB.B mice to generate transgenic lines that were homozygous for the NKC and MHC (H-2 b ) of the BALB.B strain. Using this scheme, we could use flow cytometry to simultaneously discriminate cell surface expression of the transgene-encoded and endogenously encoded Ly49A receptors using the Ly49A B6 -specific A1 mAb and the Ly49A BALB -specific TNTA mAb, respectively.
Ly49A transgene expression by NK cells
Freshly isolated splenic NK cells (DX5 ϩ CD3 Ϫ CD8 Ϫ cells) from each transgenic line were examined for expression of Ly49A by multicolor flow cytometry and compared with nontransgenic littermates. In seven of the eight lines, a clear Ly49A
B6ϩ population was evident, showing that the Ly49A transgene was expressed by NK cells in these lines ( Fig. 2A , Tables I and II) . Notably, in six of these lines (TG2, TG3, TG8, TG11, TG15, and TG16), the transgene was expressed by only a relatively small subpopulation of NK cells, representing 12.9 -28.0% of the cells, and clearly distinct from the negatively staining population. The size of this subset was similar to that of the Ly49A ϩ subset in normal B6 mice (average of 18.5% of NK cells), and larger than the fraction of NK cells in BALB.B mice that express Ly49A BALB (average of 11.2%). Within a line, the size of the transgene-positive subset varied little from mouse to mouse, as shown by the relatively small SDs of the mean (Table I ). In the remaining line that expressed the transgene, TG7, a majority of NK cells (average of 91.2%) expressed the transgene. It is possible that this transgene integrated in a chromosomal site that is active in NK cells. One transgenic line, TG9, failed to express the transgene. Thus, six of the eight lines exhibited a variegated transgene expression pattern very similar to that of the endogenous Ly49A B6 gene. Importantly, the expression of the Ly49A transgene by NK cells was not coordinate with expression of the endogenous Ly49A BALB gene. Instead, clear subpopulations were evident that expressed only the Ly49A B6 transgene, only the endogenous Ly49A BALB gene, or both ( Fig. 2A) . A similar pattern with respect to expression of Ly49A B6 and Ly49A BALB was previously observed in Ly49A heterozygous (B6 ϫ BALB.B)F 1 mice (18) . The degree of independence of expression of endogenous and transgenic Ly49A can be ascertained by comparing the degree of overlap with that predicted by the product rule. In the six lines that exhibited variegated transgene expression, the frequencies of cells that coexpressed the endogenous and transgene-encoded Ly49A receptors exceeded the predictions of the product rule by 2-to 3-fold (Table  I ). This comparison suggests that, although there is significant independence in the expression of these genes, the independence is incomplete, and some NK cells exhibit a higher probability than others of expressing both the transgene and the endogenous Ly49A gene. Strikingly, we previously observed that the frequency of NK cells in Ly49A heterozygous mice that coexpress two endogenous Ly49A alleles is also two to three times higher than predicted by the product rule (18) . These data indicate a similar bias in the expression of the transgene and endogenous Ly49A B6 genes. A comparison of the transgenic mice and their nontransgenic littermates revealed that transgene expression did not significantly alter the percentages of NK cells that express endogenous Ly49G2 and Ly49C/I receptors (data not shown). Interestingly, however, in all lines where the transgene was expressed, the percentages of NK cells expressing endogenous Ly49A (Ly49A BALB ) were marginally reduced compared with littermates (Table I) . The reductions could be the result of competition between the transgenes and endogenous genes for nuclear factors or could arise as a consequence of a cellular education process. The differences were statistically B6 wild-type (WT) genomic transgene construct used to generate transgenic mice. DNase I HSS associated with the transgenic and endogenous Ly49A loci are marked. Probes (dhs) and restriction fragments used in DNase I hypersensitive assays are indicated. A, HpaI; B, BamHI; B*, filled-in BamHI site; C, ClaI; E, EcoRI; G, BglII; H, HindIII; N, NheI; P, PstI; X, XbaI. B, Representation of the deleted (⌬HS) transgene construct used to generate transgenic mice. C, Upstream sequences of Ly49A, -C, -E, -F, -G, -I, and -J were compared with CLUSTAL W through the VectorNTI program. Graph represents the resulting similarity plot. Location of the deleted region of the ⌬HS transgene, restriction enzyme sites, and DNase I HSS are indicated along with selected consensus transcription factor binding sequences found in these Ly49 genes. Also marked are previously described TCF sites near the transcription start site (44) . CBF, CCAAT-binding factor; CTCF, CCCTCbinding factor; IK, Ikaros; GATA1, GATA binding protein 1; c-MYB, myeloblastosis proto-oncogene; Ebox, bHLH protein recognition motif (CANNTG).
significant in only two of the lines, however, and in all cases modest.
Previous research showed that the interaction of a Ly49 receptor with MHC during development can inhibit the expression of a second endogenous Ly49 receptor. Thus, the percentage of NK cells expressing endogenous Ly49 genes was substantially reduced when the mice were provided with a transgene consisting of a Ly49A or Ly49G2 cDNA driven by the K b class I promoter, which is expressed early in all developing NK cells (20, 29) . A substantial reduction only occurred when the mice also expressed a cognate MHC molecule (i.e., H-2 d ) for the cDNA transgene-encoded receptor. To investigate whether the genomic transgene is subject to similar regulation, we compared H-2 b/d littermates harboring both the genomic Ly49A transgene and the Ly49G2 cDNA transgene with those harboring the Ly49A transgene alone. The Ly49G2 transgene caused a 50% reduction in the frequency of NK cells expressing the genomic Ly49A transgene (Fig. 3A) , comparable with the reduction it caused in endogenous Ly49A expression (20) . The reduction was considerably smaller in mice that did not express a cognate MHC ligand, that is, in H-2 b/b mice. Thus, the genomic transgene, like endogenous Ly49 genes, is regulated by interactions between other Ly49 receptors and MHC ligands that occur during development.
Ontogeny of Ly49A transgene expression
Expression of most endogenous Ly49 receptors by NK cells is delayed until after birth, with the percentage of positive cells increasing progressively in the first few weeks of life (14) . Examination of three lines that exhibited variegated expression in NK cells (TG2, TG3, and TG8) revealed that the transgene exhibited a strikingly similar expression pattern in ontogeny (Fig. 3B) . NK cells from 2-day-old mice were essentially devoid of transgeneexpressing cells, with the percentage increasing to the adult value over the next several weeks.
Tissue and cell type specificity of transgene expression
The endogenous Ly49A gene is expressed by NK cells and by a small fraction of memory CD8 ϩ T cells (30) , but not by the vast majority of CD4 ϩ T cells, macrophages, B cells, or nonhemopoietic cells. Northern blot analysis of RNA from the TG2 line revealed abundant Ly49A mRNA in lymph node, lower levels in thymus, and none detectable in kidney or lung (Fig. 3C) . These data suggested that the transgene expression is limited to lymphohemopoietic cell types. Staining analysis showed no transgene expression by macrophages (Fig. 3D) or by the vast majority of 
a Nontransgenic (NTG) and TG mice from the indicated lines were analyzed for transgenic (Tg) and endogenous (Endo) Ly49A expression as in Fig. 2 .
b The predicted frequency of Ly49A CD4 ϩ T cells (Table II) , consistent with the regulation of the endogenous Ly49A gene. In contrast, in all of the lines with transgene expression in NK cells, the transgene was also expressed by a fraction of CD8 ϩ T cells (Fig. 2B) , ranging from 4.6 to 15.5% of the cells. The percentages of CD8 ϩ cells that expressed the transgene were higher than observed for expression of the endogenous Ly49A B6 gene in B6 mice of the same age (2.5-5 mo old, 1-2% of CD8 T cells). Notably, the level of surface expression of the transgene was lower on CD8 ϩ T cells than on NK cells, a pattern also observed in the case of endogenous Ly49A expression (30) . Parenthetically, BALB.B mice contain substantially fewer Ly49A ϩ
CD8
ϩ T cells than do B6 mice (Fig. 2 , B and C) (C. W. McMahon and D. H. Raulet, unpublished data).
An unexpected finding was that B cells from most of the transgenic lines aberrantly expressed the transgene (Fig. 2C , Table II ), suggesting that the transgene fragment lacks flanking sequences that repress B cell expression. Although B cell expression of the transgene is inappropriate, the pattern of transgene expression in these cells was informative, because it contrasted with the expression pattern in NK cells and CD8 ϩ T cells. In most of the transgenic lines, almost all B cells expressed the transgene (Fig. 2C) . The exceptions were the two lines that exhibited aberrant expression patterns in NK cells. In these lines, the transgene was expressed poorly (TG7) or not at all (TG9) in B cells. The finding that, in most lines, the transgene is expressed by almost all B cells, but exhibits a variegated expression pattern in NK cells, suggests that the variegated pattern is specifically imposed in NK cells.
Interestingly, analysis of the TG2, TG3, and TG8 lines demonstrated that high-level transgene expression was already evident in most B cells in 2-day-old mice and at all other ages examined (data not shown). In contrast, NK cells in 2-day-old mice failed to express the transgene (Fig. 3B ). These data demonstrate that developmentally delayed expression of the transgene in NK cells is a cell type-specific phenomenon.
Tissue-specific DNase I HSS near the Ly49A gene
To discern potential cis-acting regulatory elements in the Ly49A gene, we screened the 30-kb transgene in the TG2 line for sites that are DNase I hypersensitive in IL-2-activated NK cells. IL-2 activation did not significantly alter the percentage of NK cells that express the transgene in this or other lines examined (data not shown). DNase I hypersensitivity generally marks sites in chromatin where nuclear factors are bound. Nuclei from separated Ly49A ϩ and Ly49A Ϫ NK cells were compared. Although the Ly49A probes also detected other Ly49 genes due to high homology within this gene family, the high number of Ly49A transgene copies in the TG2 mice ensured that the transgene was preferentially detected and served also to enhance the sensitivity of site detection. Southern hybridization with the dhs1 probe (see Fig. 1A for map and probes) revealed a clear DNase I HSS, denoted HSS-1, that was localized 4.5 kb upstream of the transcription start site of the Ly49A gene (Figs. 1A and 4A ). HSS-1 was approximately equally hypersensitive in Ly49A Ϫ and Ly49A ϩ NK cells (Fig. 4A) , but was absent in liver cells (B). Similar results were obtained with NK nuclei from the TG3, TG7, TG8, and TG11 transgenic lines (data not shown). Analysis with additional restriction enzymes (data not shown) localized HSS-1 to a position just 3Ј of a BglII restriction enzyme site (Fig. 1A) . No other bands indicative of HSS were observed in the upstream region, or in the remaining portions of the transgene that were screened (see Fig. 1A for the regions examined).
HSS-1 was also clearly evident in the endogenous Ly49A B6 locus, as determined in assays using nuclei from IL-2-activated NK cells from nontransgenic (B6) mice. Again, the site was approximately equally hypersensitive in Ly49A ϩ and Ly49A Ϫ NK cells (Fig. 4C ), but absent in liver (D). The hypersensitivity of HSS-1 was also confirmed using EcoRI-digested DNA and the dhs2 probe (data not shown). Three weaker HSS were also detected at the endogenous locus that were absent or possibly obscured by other bands in all of the transgenic lines analyzed (Figs. 1A and 4) . Whereas HSS-2 was prominent, HSS-3 and HSS-4 were very weak. HSS-4 was more clearly evident, although still weak, using EcoRI-digested DNA and the dhs2 probe (data not shown). Again, these sites were approximately similarly hypersensitive in Ly49A ϩ and Ly49A Ϫ NK cells. Because the HSS-1 probe is predicted to cross-hybridize with other Ly49 genes, we cannot rule out the possibility that HSS-2-to -4 arise from a Ly49 gene other than Ly49A.
HSS-1 is essential for transgene expression
To address the functional significance of HSS-1, we prepared a transgene construct (⌬HS) that lacked a 1.9-kb HindIII-XbaI fragment containing HSS-1, but was otherwise identical with the original construct (Fig. 1B) . Five ⌬HS transgenic founders were generated, each of which was crossed back to BALB.B mice several times to generate transgenic lines. None of the ⌬HS transgenic lines exhibited detectable transgene expression in NK cells (Fig.  5) , CD8 ϩ T cells, or B cells (data not shown). These data demonstrate that the 1.9-kb region missing in the ⌬HS transgene contains an element required for transgene expression. Fig. 2 .
b Mean florescence intensities (MFI) given were determined from one experiment by staining a representative of each line with a mixture of relevant mAbs.
Conservation of upstream regions among Ly49 genes
The nucleotide sequences of the upstream regions of all the inhibitory Ly49 genes in the database were compared (Fig. 1C) . The comparison includes Ly49 genes that differ significantly in their protein-coding sequences. Overall, the upstream regions are highly conserved. A region of moderate homology flanks a region with a high degree of homology that includes HSS-1. The remainder of the upstream sequence extending to the transcription initiation site is also highly conserved. Thus, the upstream regions of the inhibitory Ly49 genes are very similar across a 4.8-kb stretch, including HSS-1. Selected transcription factor consensus binding sequences located in the deleted region of the ⌬HS transgene and conserved in all the genes are depicted in Fig. 1C . Although it is currently unknown whether any of these sites are functional, it is notable that several binding sequences exist in all of the genes, and that there is a clustering of conserved binding sites that coincides with HSS-1.
Discussion
Expression pattern of the Ly49A transgene
In several important respects, the ectopically integrated 30-kb genomic fragment containing the Ly49A gene was expressed much like the endogenous gene in most of the independent transgenic lines. Expression occurred in lymphocytes but not in several nonlymphoid tissues tested including macrophages, kidney, and lung. Like the endogenous gene, the transgene was expressed by a fraction of CD8 ϩ T cells (albeit a larger fraction than for the endogenous gene), but not by CD4 ϩ T cells. More importantly, in NK cells, a variegated expression pattern was observed in six of the The major exception to this list of similarities is that the transgene was expressed by almost all B cells in most of the lines. One likely explanation is that the 30-kb fragment lacks a flanking element(s) that represses expression in B cells but not NK cells or CD8 ϩ T cells. Alternatively, a repressive element may reside in the transgene, but its activity may be overridden as a result of the tandem cointegration of multiple transgene copies. We observed little or no transgene expression in B cells from two lines that had low numbers of transgene copies (one to three copies), but the significance of this finding is difficult to assess given that one of these lines (TG9) exhibited no transgene expression in any cells. In conclusion, although the expression in B cells is a notable exception, the transgene in most lines was regulated in a normal fashion in other key respects, especially in NK cells. The similar ontogeny, variegation, and regulation of transgene expression by other Ly49-MHC interactions leaves little doubt that the 30-kb transgene fragment contains most of the key sequences necessary for normal Ly49A gene expression.
Variegation of transgene expression
An important finding of this study is that the transgene is expressed in a variegated fashion in NK cells that recapitulates the pattern of endogenous Ly49A gene expression in all respects examined. The frequency of Ly49A
Tgϩ NK cells in most cases was comparable with the frequency of NK cells that express the endogenous Ly49A gene in B6 mice. Furthermore, the subset of NK cells that expresses the transgene is distinct from but overlaps with the population of NK cells that expresses the endogenous Ly49A gene.
Before considering the significance of this finding further, it is necessary to consider the possibility that the variegated expression pattern is due not to specific Ly49A regulatory elements, but rather reflects the phenomenon called transgene position effect variegation (PEV), after a similar phenomenon in Drosophila. It has been observed that transgenes lacking chromatin-opening regulatory regions are sometimes expressed in a variegated fashion when the corresponding endogenous gene is not (31) . Inappropriate variegated expression has been attributed to integration of transgenes near regions of constitutive heterochromatin, resulting in variable creeping of heterochromatin into the transgene (32) .
Several observations argue strongly that the variegated expression of the Ly49A genomic transgene is not due to PEV. Perhaps the most compelling was the observed expression of the transgene by all or nearly all B cells in all six of the lines that exhibited the characteristic variegated expression pattern in NK cells. The celltype specificity of variegation argues that it is imposed by a dedicated molecular mechanism operative in NK cells. A second observation inconsistent with PEV was that the HSS-1 site was equally hypersensitive in cells that expressed the transgene and cells that did not. PEV is normally due to heterochromatinization of a gene in nonexpressing cells, which would result in a closed chromatin configuration that should be inaccessible to DNase I. A third relevant finding was that the variegated NK cell expression pattern was largely independent of transgene integration site, because it was evident in nearly all of the lines (six of seven) in which the transgene was expressed. In contrast, PEV is highly dependent on integration site (32) (33) (34) (35) . A fourth significant observation was that the percentage of NK cells expressing the transgene was quite similar in all six of the lines that exhibited variegation, and averaged close to the percentage of NK cells in B6 mice that express the endogenous Ly49A B6 gene. In contrast, PEV of transgenes results in substantial variation in the percentages of expressing cells in different transgenic lines (35, 36) . Finally, the fraction of cells expressing the transgene was regulated much like that of the endogenous gene. For example, both were similarly regulated by other Ly49-MHC interactions, and the overlap between transgene and endogenous gene expression deviated from randomness in precisely the same manner as the overlap in the expression of two endogenous Ly49A alleles. As previously reported, the deviation in allelic coexpression occurs even in MHC class I-deficient mice, suggesting that it is not due to the effects of an MHC-dependent cellular selection process and is more likely explained by a generally higher likelihood of initiating Ly49A expression in some NK cell progenitors than others (18) . In conclusion, the characteristics of Ly49A transgene variegation are incompatible with PEV, and argue instead for a dedicated and regulated molecular mechanism that imposes a variegated Ly49A expression pattern in NK cells.
Significance of variegated transgene expression
This study allows several important conclusions to be drawn concerning Ly49 gene variegation. First, the results indicate that the sequences required for variegation are present in the 30-kb Ly49A transgene fragment and that the transgenic system is suitable for analysis of Ly49 gene variegation. This will facilitate the identification of the relevant sequences and the elucidation of the underlying mechanisms.
Second, the finding that the transgene-expressing subset is to a significant extent independent of the fraction that expresses endogenous Ly49A, albeit overlapping, implies that the expression of Ly49A is not directed to a predetermined subpopulation of NK cells. The data argue that variegation of Ly49A gene expression cannot be explained by the variegated expression of essential Ly49A-specific transcription factors in only a subset of NK cells.
Third, and perhaps most important, the results indicate that appropriate Ly49A gene variegation does not require interactions or competition between different Ly49 genes in the endogenous multigene array. This finding argues against models in which a master control element(s) in the endogenous Ly49 array somehow selects a subset of the Ly49 genes for expression. For example, it could be imagined that an element such as a locus control region (LCR) in the endogenous locus stably associates in cis with only one or a few of the 10 or so Ly49 genes in the array, activating only these genes. Because the ectopically integrated Ly49A transgene exhibits a variegated expression pattern, this possibility is rendered highly unlikely. One might propose that the putative LCR resides within the 30-kb Ly49A transgene sequence, and selects among the different tandemly integrated Ly49A transgene copies as if each copy were a different Ly49 gene in the endogenous array. However, this would result in all NK cells expressing the transgene, albeit different copies of it. Because this was not observed, the data argue against models in which the primary determinant of variegation is a competition in cis between neighboring Ly49 genes for a common regulatory element. However, this does not mean that cis competition between genes does not play some role in the process.
Based on our findings that Ly49A gene variegation is largely independent of neighboring Ly49 genes, and occurs in largely independent sets of NK cells for different Ly49 alleles, genes, or transgenes, we favor a model in which variegation results from limitations in trans-acting factors that bind to Ly49 gene regulatory elements and are necessary to stably activate gene expression. As discussed elsewhere, such factors might be limiting in the sense that only a few molecules are available in the nucleus or in a nuclear compartment in which Ly49 genes are localized. An alternative possibility is that complete assembly of the necessary factors on the relevant regulatory sequence(s) is an inefficient process, and therefore occurs in only a fraction of developing NK cells in a limited time window allotted for this to occur (3, 16) .
A recent report described mice with transgenes representing a large (160-kb) genomic segment, each containing 10 human killer Ig-related receptor (KIR) genes, and showed that the KIR genes are expressed in an appropriate variegated pattern in NK cells (37) . Their conclusions are largely distinct from ours, which emphasize appropriate variegation in the absence of competing genes in cis, nonoverlapping expression with endogenous genes, and variegated expression with a relatively small genomic fragment.
A curious feature of our results was that neither the size nor the cell surface staining intensity of the transgene-expressing subset correlated well with transgene copy number (see Table II , which includes transgene copy numbers). Our understanding of the Ly49 gene variegation mechanism is too limited to allow simple predictions to be made as to how transgene copy number should influence the frequency of NK cells expressing the transgene. However, the relative independence of the extent of variegation from copy number observed in this study is an interesting clue with respect to the mechanism of variegation. In terms of the level of transgene expression, copy number dependence of transgene expression is often due to the action of chromatin-opening elements such as LCRs, defined as elements that confer copy number dependence and position independence to a transgene (38) . The fact that seven of eight transgenic lines exhibited substantial levels of expression might suggest that an element with chromatin-opening activity is present, but further studies will be necessary to definitively address whether the Ly49A gene contains a bona fide LCR.
A tissue-specific DNase I HSS, HSS-1, is essential for transgene expression
The transgenic system facilitated the identification of HSS-1 4.5 kb upstream of the transcription start site of the Ly49A gene. HSS-1 was DNase I hypersensitive in NK cells but not in liver cells, and was essential for transgene expression. Therefore, HSS-1 is highly likely to play an important role in regulating the Ly49A gene in its natural genomic location, and is a strong candidate for an element involved in the variegation of Ly49A gene expression.
Interestingly, HSS-1 is equally DNase I hypersensitive in Ly49A ϩ and Ly49A Ϫ NK cells. It is known that the DNase hypersensitivity of elements involved in cell-specific regulation is not always correlated with the expression pattern (39, 40) . It is possible that the repressed and expressed HSS-1 alleles are occupied with different proteins or are differentially modified in other respects, for example, by DNA methylation or local histone modifications. It is also important to emphasize that the monoallelic expression pattern of the gene means that a significant fraction of Ly49A alleles in the Ly49A ϩ population are inactive, complicating the comparison between Ly49A ϩ cells and Ly49A Ϫ cells. The comparison in Fig. 1C reveals an extremely high degree of conservation of the HSS-1 region in all inhibitory Ly49 sequences even though the coding sequences in some of the sequences exhibit as little as 56% identity in pairwise comparisons. The high degree of sequence conservation begins just 5Ј to HSS1, consistent with an important role for this region in expression of all Ly49 genes. Several transcription factor consensus binding sequences are identical in all of the inhibitory Ly49 genes in the region deleted from the ⌬HS transgene. Among these are possible sites for CCCTC-binding factor, which have been shown to define insulator sequences in vertebrate genes (41) , and Ikaros, which mediates chromatin relocalization within the nucleus (42) .
Interestingly, HSS-1 corresponds to a homologous site in the Ly49G gene called Pro-1, which was recently shown to exhibit promoter activity in immature NK cells in the bone marrow (43) . In mature NK cells, a downstream promoter called Pro-2 was active and Pro-1 was not, leading to the suggestion that Pro-1 plays some role in initiating Ly49 gene expression. Tests of whether the HSS-1 fragment of Ly49A exhibits promoter activity in an immature NK cell line, LNK5E6, yielded inconclusive results (data not shown). In line with expectations (43), the HSS-1 fragment did not exhibit detectable promoter or enhancer activity in the assays we performed in a mature cell line, EL-4.
A previous study implicated T cell-specific factor (TCF)-1 in regulation of the Ly49A gene, and suggested that the dosage of TCF might influence the percentage of cells expressing this gene (44) . On this basis, it was proposed that TCF-1 might represent the limiting factor that determines Ly49A gene variegation. Several sites in the proximal promoter region of Ly49A were identified that bind TCF-1 in vitro and which might therefore be targets for TCF-1 in vivo. Our results presented in this study demonstrate that the promoter-proximal TCF-1 sites are not sufficient for transgene expression, because they are present in the ⌬HS transgene, which is not expressed. Notably, many other potential TCF-1 sites exist in the upstream region of Ly49A, including one that is conserved in the deleted region of the ⌬HS transgene in all but one (Ly49F) of the genes aligned here. It will be important to assess the role of the various TCF-1 sites in the promoter and the upstream region in future studies.
The results presented in this report concerning the variegation of Ly49 genes are likely to have significance for understanding the basis of variegated expression observed in other systems, such as KIR, olfactory receptors, cytokine genes, and transcription factors such as Pax-5 (19) . Although a recent report suggests that variegated expression of KIR genes is maintained by gene methylation, the study did not address how KIR gene variegation is initially established (45) . Variegated gene expression may play a role not only in forming repertoires but also in directing stochastic developmental decisions. Thus, it is likely that the number of examples of variegated gene expression will continue to grow. An understanding of the mechanisms of variegation will be essential in elucidating the regulation of this category of genes.
